Baxarias, M., Donato, G., Mateu, C., Salichs, M., Homedes, J., Miró Corrales, G., . . . Solano Gallego, L. (2023). A blinded, randomized and controlled multicenter clinical trial to assess the efficacy and safety of Leisguard® as an immunotherapeutic treatment for healthy Leishmania infantum-seropositive dogs.
Chicago Style CitationBaxarias, Marta, Giulia Donato, Cristina Mateu, Marta Salichs, Josep Homedes, Guadalupe Miró Corrales, Maria Grazia Pennisi, and Laia Solano Gallego. A Blinded, Randomized and Controlled Multicenter Clinical Trial to Assess the Efficacy and Safety of Leisguard® As an Immunotherapeutic Treatment for Healthy Leishmania Infantum-seropositive Dogs. 2023.
MLA CitationBaxarias, Marta, et al. A Blinded, Randomized and Controlled Multicenter Clinical Trial to Assess the Efficacy and Safety of Leisguard® As an Immunotherapeutic Treatment for Healthy Leishmania Infantum-seropositive Dogs. 2023.